Glytec and Ardent Join Forces to Transform Diabetes Care
In a significant move to advance healthcare, Glytec, a leader in diabetes management technology, has partnered with Ardent Health, a prominent healthcare provider. This collaboration is set to enhance diabetes and insulin management for patients across Ardent's extensive network of hospitals and clinics.
The Importance of Diabetes Management
Diabetes is a growing health challenge, impacting over 37 million individuals. The need for effective diabetes management has never been more crucial, especially as a substantial number of hospitalized patients require insulin therapy. This partnership promises to bring improved safety and quality of care, addressing a vital public health issue.
Innovative Solutions for Better Care
Brad Hoyt, MD, chief medical information officer at Ardent, emphasizes the commitment to offering top-quality care. He states, "Partnering with Glytec allows us to harness innovative solutions that tackle diabetes management challenges. Their technology equips care teams with the tools needed to enhance patient safety and outcomes, ensuring exceptional care delivery."
Empowering Care Teams with Technology
As Glytec rolls out its advanced insulin management software, the integration into Ardent's operations aims to streamline clinical workflows. Healthcare professionals will be able to deliver personalized care, leading to improved efficiency in managing diabetes. The collaboration will ultimately translate to lower costs of care through fewer complications and reduced hospital stays.
Benefits of the Glytec and Ardent Partnership
Jordan Messler, MD, Glytec's chief medical officer, highlights several key advantages stemming from this partnership:
- Improved Patient Outcomes: By leveraging data-driven algorithms, Glytec's technology will enhance insulin therapy, reducing complications and minimizing hospital stay durations.
- Streamlined Workflow: The integration of Glytec's platform will simplify the processes for clinicians, enabling them to provide tailored care more efficiently.
- Cost Reduction: By decreasing adverse events related to diabetes management, this advanced system aims to lower overall care costs.
Future Plans for Implementation
The initial rollout of Glytec's diabetes technology will occur at select Ardent facilities, with plans to expand the system to all locations over the coming months. This phased approach ensures that technology adoption is seamless, fostering improvements in patient care across the entire network.
About Glytec
Glytec has established itself as a leader in the diabetes management sector, powering over 350 hospitals through its innovative Software-as-a-Service (SaaS) platform. Their approach not only improves patient outcomes but also significantly reduces hospital stays and enhances clinical workflows. Glytec's Glucommander solution integrates easily with electronic medical records (EMR), boasting a proven track record validated by numerous patents and publications. With a mission to promote health equity, Glytec aims to improve health outcomes for patients across the continuum of care—from hospital settings to home.
Frequently Asked Questions
What is the main focus of the Glytec and Ardent partnership?
The partnership primarily focuses on advancing diabetes and insulin management across Ardent's network of hospitals and clinics.
How does Glytec's technology benefit patients?
Glytec's technology enhances insulin therapy and reduces the risk of complications, leading to improved patient outcomes and shorter hospital stays.
What are the expected outcomes of the partnership for healthcare providers?
The partnership is anticipated to streamline workflows for healthcare providers, allowing for more efficient and personalized patient care.
What strategies will be employed to implement Glytec's technology?
The implementation will begin at key locations within Ardent's network and will gradually expand to all facilities to ensure effective integration.
Why is diabetes management crucial in hospital settings?
A significant number of hospitalized patients require insulin therapy, making effective diabetes management essential for ensuring patient safety and optimal outcomes.
